Association For Molecular Pathology et al v. United States Patent and Trademark Office et al
Filing
194
RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Celera Corporation, Genomic Health, Inc., QIAGEN, N.V..(Huttenlocher, Michael)
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al
Doc. 194
IN THE UNITED STATES DISTRICT COURT IN AND FOR THE SOUTHERN DISTRICT OF NEW YORK
ASSOCIATION FOR MOLECULAR PATHOLOGY, et al., Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE, et al., Defendants.
CASE NO. 09-CV-4515 (RWS) ECF RULE 7.1 CORPORATE DISCLOSURE STATEMENT
Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, nonparties and proposed Amici Curiae Celera Corporation, Genomic Health, Inc. and QIAGEN, N.V. state that none of these entities have a parent corporation and that no publicly held corporation owns 10% or more stock in these proposed Amici Curiae. DATED: January 6, 2010 Respectfully Submitted, By: /s/ Michael R. Huttenlocher Michael R. Huttenlocher Obiamaka P. Madubuko MCDERMOTT WILL & EMERY LLP 340 Madison Avenue New York, NY 10173-1922 Telephone: (212) 547-5400 Facsimile: (212) 547-5444 omadubuko@mwe.com
Of Counsel: William G. Gaede, III Andrew A. Kumamoto MCDERMOTT WILL & EMERY LLP 275 Middlefield Road, Suite 100 Menlo Park, CA 94025 wgaede@mwe.com akumamoto@mwe.com
Counsel of Record for Amici Curiae
-1MPK 160247-1.009900.0023
Dockets.Justia.com
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?